BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28971860)

  • 1. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
    Panic G; Ruf MT; Keiser J
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
    Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
    Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
    Fallon PG; Hamilton JV; Doenhoff MJ
    Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
    Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
    Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
    Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal.
    Keiser J; Panic G; Vargas M; Wang C; Dong Y; Gautam N; Vennerstrom JL
    J Antimicrob Chemother; 2015; 70(6):1788-97. PubMed ID: 25691324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
    Buchter V; Hess J; Gasser G; Keiser J
    Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice.
    Silva LM; Menezes RM; de Oliveira SA; Andrade ZA
    Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between schistosomicidal drug efficacy, gonadal steroid hormonal changes and state of disease immunopathology in murine schistosomiasis mansoni.
    Botros SS; Salama SH; Estafan MY; Gomaa NE; Metwally AA; Ebeid FA
    Pharmacol Res; 1990; 22(3):359-70. PubMed ID: 2114615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
    Keiser J; Manneck T; Vargas M
    J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing.
    Frahm S; Anisuzzaman A; Prodjinotho UF; Vejzagić N; Verschoor A; Prazeres da Costa C
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006590. PubMed ID: 30689639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment.
    Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK
    Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for treating Schistosoma mansoni infection.
    Danso-Appiah A; Olliaro PL; Donegan S; Sinclair D; Utzinger J
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD000528. PubMed ID: 23450530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.